DE LUCA, Michele

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Info

Pubblicazioni (Tutti)

Risultati 1 - 20 di 149 (tempo di esecuzione: 0.001 secondi).

	Titolo	Data di pubblicazione	Autore(i)
1	A volume-sensitive chloride conductance revealed in cultured human keratinocytes by 36Cl- efflux and whole-cell patch clamp recording	1992	Rugolo, M; Mastrocola, T; De Luca, M; Romeo, G; Galietta, L J
2	Vision from the right stem. [5YIF: 9.93; Citations: 13]	2011	G. Pellegrini; P. Rama; M. De Luca
3	Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes	1998	Bellini, M H; Mathor, M B; De Luca, M; Cancedda, R; Bartolini, P
4	TSH receptor structure	1987	Chan J.; Santisteban P.; De Luca M.; Isozaki O.; Grollman E.; Kohn L.D.
5	Treatment of “stable” vitiligo by timedsurgery and transplantation of cultured epidermal autografts.	2000	L. Guerra; S. Capurro; F. Melchi; G. Primavera; S. Bondanza; R. Cancedda; A. Luci; M. De Luca; G. Pellegrini
6	Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium.	1990	ROMAGNOLI G.; M. DE LUCA; FARANDA F.; BANDELLONI R.; FRANZI A.T.; CATALIOTTI F.; CANCEDDA R.
7	Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study	1992	De Luca, M; Albanese, E; Cancedda, R; Viacava, A; Faggioni, A; Zambruno, G; Giannetti, A
8	Transforming Growth-Factor-Beta-1 Modulates Beta-1 And Beta-5 Integrin Receptors And Induces The De-Novo Expression Of The Alpha-V-Beta-6 Heterodimer In Normal Human Keratinocytes - Implications For Wound-Healing. [5YIF: 10.77; Citations: 268]	1995	G. Zambruno; P. C. Marchisio; A. Marconi; C. Vaschieri; A. Melchiori; A. Giannetti; M. De Luca
9	Transforming Growth-Factor (TGF)-Beta(1) Enhances Alpha(5)Beta(1) And Alpha(V)Beta(5) Integrin Expression And Migration Of Normal Human Keratinocytes	1994	G. Zambruno; A. Marconi; A. Melchiori; P. C. Marchisio; A. Giannetti; M. De Luca
10	Towards therapeutic application of ocular stem cells.	2007	Pellegrini G; De Luca M; Arsenijevic Y.
11	Towards a gene therapy clinical trial for epidermolysis bullosa	2006	FERRARI S; G. PELLEGRINI; Matsui T; MAVILIO F; DE LUCA M;
12	Toward gene therapy of junctional epidermolysis bullosa (JEB)	2002	De Luca M; Dellambra E; Pellegrini G; Guerra L; Bondanza S; Mavilio F
13	Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa	2000	E. DELLAMBRA; G. PELLEGRINI; L. GUERRA; G. FERRARI; G. ZAMBRUNO; F. MAVILIO; M. DE LUCA
14	Topography and biological role of integrins in human skin	1997	Marchisio, P C; Trusolino, L; De Luca, M
15	Tissue engineering for clinical application	1993	Cancedda, R; De Luca, M
16	Thyrotropin Receptor: Characterization and Purification	1990	Akamizu T.; De Luca M.; Kohn L.D.
17	Thyroglobulin interaction with thyroid membranes: implications for regulation of thyroid hormone formation	1985	Kohn L.D.; De Luca M.; Santisteban P.; Shifrin S.; Yeh H.; Formisano S.; Consiglio E.
18	THS receptor mediated growth of thyroid cells: mechanism and relation to autoimmune thyroid diseases	1984	Aloj, S.M.; Marcocci, C.; De Luca, M.; Shifrin, S.; Grollman, E.F.; Kohn, L.D.
19	The Ocular Albinism type 1 gene product is a membrane glycoprotein localized to melanosomes.	1996	M.V. SCHIAFFINO; C. BASCHIROTTO; G. PELLEGRINI; S. MONTALTI; C. TACCHETTI; M. DE LUCA; A. BALLABIO
20	The importance of epidermal stem cells in keratinocyte-mediated gene therapy	1997	M. DE LUCA; G. PELLEGRINI

Dettaglio

Nome completo:

DE LUCA, Michele